Cell-Extracellular Matrix Dynamics

Introduction

  • Historical Perspective: The extracellular matrix (ECM) was initially viewed primarily as structural support within tissues and organs, lacking any significant functional role in cellular interactions. This perspective has evolved dramatically with advances in research.

  • Shift in Understanding: Increased understanding of the ECM revealed its critical roles in various cellular processes. For instance, mammary gland epithelial cells cultured on Engelbreth-Holm-Swarm (EHS) matrix, which closely resembles natural basement membranes, synthesized critical milk molecules and underwent branching morphogenesis, showcasing the ECM's influence on cellular behavior and functionality. These findings indicate that cells possess specific receptors for matrix molecules, which are essential for signaling during embryonic development and tissue differentiation.

  • Dynamic Reciprocity Model: This model emphasizes the bidirectional interplay wherein ECM components interact with cell-surface receptors, initiating a cascade of intracellular signal transduction pathways that promote the expression of specific genes—this gene expression subsequently affects the ECM composition and functionality.

  • Mechanisms Regulated by Matrix Molecules: Matrix molecules are fundamental regulators of numerous cellular processes, including:

    • Cell adhesion: The ability of cells to adhere to one another and extracellular structures is critical for tissue integrity.

    • Migration: ECM components guide cellular movement necessary for processes such as wound healing and development.

    • Growth: The ECM supports cell proliferation by providing necessary biochemical signals.

    • Differentiation: Specific ECM interactions can promote stem cell differentiation into specialized cell types.

    • Apoptosis: ECM signals can influence programmed cell death, crucial for maintaining tissue homeostasis.

    • Modulation of Cytokine and Growth Factor Signaling: The ECM can interact with signaling molecules, modifying their activity and availability to cells.

    • Stimulation of Intracellular Signaling: ECM influences various intracellular pathways essential for cell survival and function.

  • Research Approach: This field utilizes a combination of in vitro cell cultures with matrix molecules alongside in vivo experiments using animal models genetically manipulated to lack specific matrix molecules or their corresponding receptors, providing insights into ECM functions and their impact on health and disease.

  • Focus: This chapter highlights key ECM molecules and their corresponding receptors while discussing the significance of cell-matrix interactions in diverse processes such as development, wound healing, and in the engineering of artificial tissues for therapeutic purposes.

Extracellular Matrix Composition

  • Components: The ECM comprises traditional structural components including;

    • Fibronectin, providing adhesive properties;

    • Hyaluronic Acid, which retains moisture and facilitates movement of cells;

    • Proteoglycans, that trap growth factors;

    • Collagens, which impart tensile strength;

    • Glycosaminoglycans, contributing to hydration and molecular filtration; and

    • Elastins, which allow tissues to return to their original shape after stretching.

    • It also contains nonstructural matricellular proteins (e.g., SPARC, tenascin, osteopontin, thrombospondins) that play regulatory roles in cellular functions.

  • Dynamic Distribution: The distribution and spatial organization of ECM components vary significantly between different tissues and during various developmental stages, which profoundly impacts tissue functionality and cellular behavior.

    • Mesenchymal Cells typically are immersed in the interstitial matrix, while Epithelial and Endothelial Cells make contact with the basement membrane through their basal surfaces, anchoring them and providing necessary signals for maintenance.

  • Alterations in ECM: Changes in the ECM's temporal and spatial composition occur due to:

    • Differential gene expression, allowing for context-specific ECM synthesis.

    • Alternative splicing processes modify protein binding potential increasing functional diversity.

    • Post-Translational Modifications like glycosylation, affecting cell adhesion and migration properties.

    • Proteolytic Cleavage of ECM components generates fragments that can exhibit unique biological activities distinct from their parent molecules.

  • Indirect Effects: The ECM also interacts with non-matrix proteins, including growth factors and cytokines, influencing tissue functionality. Variations in ECM composition can regulate the capacity of associated molecules to elicit intracellular signaling, limiting diffusion, protecting molecules from degradation, presenting them to cell receptors, or sequestering them to modulate availability.

Examples of ECM Interactions

  • VEGF and HSPGs: The vascular endothelial growth factor (VEGF) binds to heparan sulfate proteoglycans (HSPGs), which boosts its availability to and activation of VEGF receptors, crucial for angiogenesis.

  • HB-EGF and Proteoglycans: The interaction of heparin-binding epidermal growth factor (HB-EGF) with proteoglycans alters its receptor activation until the binding is released through proteoglycan degradation.

  • Matricryptins: Specific functional domains within ECM molecules, or fragments derived from proteolysis, can bind directly to growth factor receptors. For example:

    • EGF-like repeats present in laminin or tenascin-C can activate the EGF receptor (EGFR).

    • Contrarily, the proteoglycan decorin acts to inhibit several growth factor receptors, including EGFR and VEGFR2, thus modulating signaling downstream.

    • The activity of VEGFVEGF is impacted by these dynamics.

  • Regulation of Growth Factor Receptors: Intact ECM components can provide a stable signaling environment due to restricted ligand diffusion or internalization, facilitating sustained signaling interactions essential for cell function.

  • Proteolytic Cleavage: Matricryptins generated from proteolytic cleavage can have transient effects on cellular functions, as they may diffuse away from the ECM and be internalized by cells, such as endorepellin and endostatin, which inhibit VEGFR2VEGFR2 activation.

  • Complex Network: The interactions between matrix molecules, growth factors, and their receptors form a multifaceted network, yielding synergistic and complex effects on cell survival, growth, and overall tissue homeostasis.

Receptors for Extracellular Matrix Molecules

  • Cell-Surface Receptors: These molecules are crucial in mediating cell-matrix interactions whereby extracellular binding events translate into intracellular signaling pathways that dictate cell behavior.

  • Integrins: - The first identified ECM receptors consist of heterogeneous transmembrane proteins made from paired "a"a and "b"b subunits.

    • There are 18 distinct "a"a subunits and 8 "b"b subunits that combine to form 24 unique heterodimers, each recognizing specific sequences on ligands, predominantly the RGD motif found in fibronectin, vitronectin, thrombospondin, and fibrinogen.

    • Some integrins are characterized by ligand specificity, while others are capable of interacting with multiple ligands, thereby enabling cellular plasticity and redundancy.

    • Integrins possess large extracellular domains, which facilitate ligand binding, and relatively smaller intracellular domains (with the exception of integrin "b4"b4).

    • They connect intracellular proteins with the cytoskeleton, activating various signal transduction pathways necessary for regulating physiological processes and can bind non-matrix molecules (ICAM1-3, VCAM1, RGD-containing cadherins), mediating cell-cell adhesions.

    • The interplay between integrin "a"b3"a"b3 and the fibroblast growth factor (FGF) receptor (FGFR) as well as VEGFR2VEGFR2 has been elucidated through integrin knockout and inhibition experiments to clarify matrix-induced integrin signaling events.

  • Transmembrane Proteoglycans: - Syndecans, RHAMM (receptor for hyaluronan-mediated motility), and CD44 can serve as receptors for ECM molecules (collagen, fibronectin, laminin, and hyaluronan).

    • Syndecans 1-4 mediate cell-ECM interactions via chondroitin- and heparan sulfate glycosaminoglycans. Glycosaminoglycan modifications alter ligand binding capacity.

    • Short cytoplasmic domains interact with signaling proteins and cytoskeleton, inducing signal transduction. They can directly activate downstream signaling or mediate the formation of larger signaling complexes that indirectly activate signaling.

    • Syndecan protein cores bind some integrins, while heparan sulfate moieties bind growth factors and matrix molecules.

Other ECM Receptors

  • CD44: interacts with multiple matrix ligands, including collagen IV, collagen XIV, fibronectin, osteopontin, and laminin, in addition to hyaluronan. It is regulated by tissue-specific splicing and glycosylation that yield multiple isoforms.

  • RHAMM: a peripheral membrane receptor that must bind transmembrane proteins (CD44, integrins, receptor tyrosine kinases) to transmit signals from hyaluronan.

  • Hyaluronan:- Native high molecular weight form.

    • Low molecular weight fragments generated by hyaluronidases and reactive oxygen or nitrogen species.

    • Native and cleaved forms elicit different cellular responses due to differential receptor selectivity.

    • CD44 binds more stably to high molecular weight hyaluronan.

    • Hyaluronan fragments bind and activate toll-like receptors (TLRs), functioning as immune signaling molecules, demonstrating a crucial role in modulating immune responses and tissue repair processes, thus highlighting its importance in the ECM.

Introduction

  • Historical Perspective: The extracellular matrix (ECM) was initially viewed primarily as structural support within tissues and organs, lacking any significant functional role in cellular interactions. This perspective has evolved dramatically with advances in research.

  • Shift in Understanding: Increased understanding of the ECM revealed its critical roles in various cellular processes. For instance, mammary gland epithelial cells cultured on Engelbreth-Holm-Swarm (EHS) matrix, which closely resembles natural basement membranes, synthesized critical milk molecules and underwent branching morphogenesis, showcasing the ECM's influence on cellular behavior and functionality. These findings indicate that cells possess specific receptors for matrix molecules, which are essential for signaling during embryonic development and tissue differentiation.

  • Dynamic Reciprocity Model: This model emphasizes the bidirectional interplay wherein ECM components interact with cell-surface receptors, initiating a cascade of intracellular signal transduction pathways that promote the expression of specific genes—this gene expression subsequently affects the ECM composition and functionality.

  • Mechanisms Regulated by Matrix Molecules: Matrix molecules are fundamental regulators of numerous cellular processes, including:

    • Cell adhesion: The ability of cells to adhere to one another and extracellular structures is critical for tissue integrity.

    • Migration: ECM components guide cellular movement necessary for processes such as wound healing and development.

    • Growth: The ECM supports cell proliferation by providing necessary biochemical signals.

    • Differentiation: Specific ECM interactions can promote stem cell differentiation into specialized cell types.

    • Apoptosis: ECM signals can influence programmed cell death, crucial for maintaining tissue homeostasis.

    • Modulation of Cytokine and Growth Factor Signaling: The ECM can interact with signaling molecules, modifying their activity and availability to cells.

    • Stimulation of Intracellular Signaling: ECM influences various intracellular pathways essential for cell survival and function.

  • Research Approach: This field utilizes a combination of in vitro cell cultures with matrix molecules alongside in vivo experiments using animal models genetically manipulated to lack specific matrix molecules or their corresponding receptors, providing insights into ECM functions and their impact on health and disease.

  • Focus: This chapter highlights key ECM molecules and their corresponding receptors while discussing the significance of cell-matrix interactions in diverse processes such as development, wound healing, and in the engineering of artificial tissues for therapeutic purposes.

Extracellular Matrix Composition

  • Components: The ECM comprises traditional structural components including;

    • Fibronectin, providing adhesive properties;

    • Hyaluronic Acid, which retains moisture and facilitates movement of cells;

    • Proteoglycans, that trap growth factors;

    • Collagens, which impart tensile strength;

    • Glycosaminoglycans, contributing to hydration and molecular filtration; and

    • Elastins, which allow tissues to return to their original shape after stretching.

    • It also contains nonstructural matricellular proteins (e.g., SPARC, tenascin, osteopontin, thrombospondins) that play regulatory roles in cellular functions.

  • Dynamic Distribution: The distribution and spatial organization of ECM components vary significantly between different tissues and during various developmental stages, which profoundly impacts tissue functionality and cellular behavior.

    • Mesenchymal Cells typically are immersed in the interstitial matrix, while Epithelial and Endothelial Cells make contact with the basement membrane through their basal surfaces, anchoring them and providing necessary signals for maintenance.

  • Alterations in ECM: Changes in the ECM's temporal and spatial composition occur due to:

    • Differential gene expression, allowing for context-specific ECM synthesis.

    • Alternative splicing processes modify protein binding potential increasing functional diversity.

    • Post-Translational Modifications like glycosylation, affecting cell adhesion and migration properties.

    • Proteolytic Cleavage of ECM components generates fragments that can exhibit unique biological activities distinct from their parent molecules.

  • Indirect Effects: The ECM also interacts with non-matrix proteins, including growth factors and cytokines, influencing tissue functionality. Variations in ECM composition can regulate the capacity of associated molecules to elicit intracellular signaling, limiting diffusion, protecting molecules from degradation, presenting them to cell receptors, or sequestering them to modulate availability.

Examples of ECM Interactions

  • VEGF and HSPGs: The vascular endothelial growth factor (VEGF) binds to heparan sulfate proteoglycans (HSPGs), which boosts its availability to and activation of VEGF receptors, crucial for angiogenesis.

  • HB-EGF and Proteoglycans: The interaction of heparin-binding epidermal growth factor (HB-EGF) with proteoglycans alters its receptor activation until the binding is released through proteoglycan degradation.

  • Matricryptins: Specific functional domains within ECM molecules, or fragments derived from proteolysis, can bind directly to growth factor receptors. For example:

    • EGF-like repeats present in laminin or tenascin-C can activate the EGF receptor (EGFR).

    • Contrarily, the proteoglycan decorin acts to inhibit several growth factor receptors, including EGFR and VEGFR2, thus modulating signaling downstream.

    • The activity of VEGFVEGF is impacted by these dynamics.

  • Regulation of Growth Factor Receptors: Intact ECM components can provide a stable signaling environment due to restricted ligand diffusion or internalization, facilitating sustained signaling interactions essential for cell function.

  • Proteolytic Cleavage: Matricryptins generated from proteolytic cleavage can have transient effects on cellular functions, as they may diffuse away from the ECM and be internalized by cells, such as endorepellin and endostatin, which inhibit VEGFR2VEGFR2 activation.

  • Complex Network: The interactions between matrix molecules, growth factors, and their receptors form a multifaceted network, yielding synergistic and complex effects on cell survival, growth, and overall tissue homeostasis.

Receptors for Extracellular Matrix Molecules

  • Cell-Surface Receptors: These molecules are crucial in mediating cell-matrix interactions whereby extracellular binding events translate into intracellular signaling pathways that dictate cell behavior.

  • Integrins: - The first identified ECM receptors consist of heterogeneous transmembrane proteins made from paired "a"a and "b"b subunits.

    • There are 18 distinct "a"a subunits and 8 "b"b subunits that combine to form 24 unique heterodimers, each recognizing specific sequences on ligands, predominantly the RGD motif found in fibronectin, vitronectin, thrombospondin, and fibrinogen.

    • Some integrins are characterized by ligand specificity, while others are capable of interacting with multiple ligands, thereby enabling cellular plasticity and redundancy.

    • Integrins possess large extracellular domains, which facilitate ligand binding, and relatively smaller intracellular domains (with the exception of integrin "b4"b4).

    • They connect intracellular proteins with the cytoskeleton, activating various signal transduction pathways necessary for regulating physiological processes and can bind non-matrix molecules (ICAM1-3, VCAM1, RGD-containing cadherins), mediating cell-cell adhesions.

    • The interplay between integrin "a"b3"a"b3 and the fibroblast growth factor (FGF) receptor (FGFR) as well as VEGFR2VEGFR2 has been elucidated through integrin knockout and inhibition experiments to clarify matrix-induced integrin signaling events.

  • Transmembrane Proteoglycans: - Syndecans, RHAMM (receptor for hyaluronan-mediated motility), and CD44 can serve as receptors for ECM molecules (collagen, fibronectin, laminin, and hyaluronan).

    • Syndecans 1-4 mediate cell-ECM interactions via chondroitin- and heparan sulfate glycosaminoglycans. Glycosaminoglycan modifications alter ligand binding capacity.

    • Short cytoplasmic domains interact with signaling proteins and cytoskeleton, inducing signal transduction. They can directly activate downstream signaling or mediate the formation of larger signaling complexes that indirectly activate signaling.

    • Syndecan protein cores bind some integrins, while heparan sulfate moieties bind growth factors and matrix molecules.

Other ECM Receptors

  • CD44: interacts with multiple matrix ligands, including collagen IV, collagen XIV, fibronectin, osteopontin, and laminin, in addition to hyaluronan. It is regulated by tissue-specific splicing and glycosylation that yield multiple isoforms.

  • RHAMM: a peripheral membrane receptor that must bind transmembrane proteins (CD44, integrins, receptor tyrosine kinases) to transmit signals from hyaluronan.

  • Hyaluronan:- Native high molecular weight form.

    • Low molecular weight fragments generated by hyaluronidases and reactive oxygen or nitrogen species.

    • Native and cleaved forms elicit different cellular responses due to differential receptor selectivity.

    • CD44 binds more stably to high molecular weight hyaluronan.

    • Hyaluronan fragments bind and activate toll-like receptors (TLRs), functioning as immune signaling molecules, demonstrating a crucial role in modulating immune responses and tissue repair processes, thus highlighting its importance in the ECM.